Structural Heart Devices Market to Gain Significant Traction as Medtronic Partners with The Foundry, a medical device company, to develop innovative Mitral Valve Repair Technology
Structural heart devices are medical
devices with the ability to pump blood by way of the heart. This device is
called the ventricular myocardium, and it is what pumps blood from the heart to
the various chambers of the body. The structure that this type of heart device
has is very basic - a couple of stacks of cells (or more, depending upon the
desired function), and a tubing filled with fluid that can allow for the
movement of the cells. This particular construction has allowed these devices
to be built so that they can pump blood and create heart attacks and heart
failure with much greater efficiency.
Increasing prevalence of structural
heart diseases such as valvular heart disease, cardiomyopathy, and Marfan
syndrome is expected to drive growth of the global structural heart devices
market during the forecast period. According to the Centers for Disease Control
Prevention (CDC), 1 in 500 adults in the U.S. may have cardiomyopathy of all
ages. According to the CDC, in 2017, there were around 3,046 deaths due to
rheumatic valvular heart disease and 24,811 deaths due to non-rheumatic
valvular heart disease in the U.S. Such a massive increase in structural heart
disease has increased the demand for structural heart devices. Hence, these
factors are expected to drive growth of the global structural heart devices
market. Furthermore, increasing product approvals and of advanced structural
heart devices is expected to propel the global structural
heart devices market growth in the near future.
Lack of skilled personnel and low
affordability is expected to restrain growth of the global structural heart
devices market during the forecast period. However, the emergence of
tissue-engineered heart valves and the advent of percutaneous interventions can
offer major business opportunities in the global structural heart devices
market. Among regions, North America is expected to witness significant growth
in the global structural heart devices market during the forecast period. This
is owing to growing preference for minimally invasive procedures in the region.
Furthermore, Asia Pacific is expected to register a robust growth rate, owing
to increasing awareness regarding cardiac diseases.
Key players involved in the global
structural heart devices market are Boston Scientific Corporation,
CardioKinetix, Medtronic, JenaValve Technology, Inc., Edwards Lifesciences
Corporation, LivaNova plc, Abbott Laboratories, Comed BV, ST. Jude Medical, and
Biomerics.
For instance, in October 2020,
Medtronic, a major medical technology company, partnered with The Foundry, a
medical device company, to develop innovative Mitral Valve Repair Technology.

Comments
Post a Comment